Position in HIMS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$798,100
+$413,585 QoQ
Shares Held
23,020
+24.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#231
of 504 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026M&T Bank Corp holds $21,859,084 across 15 Drug Manufacturers - Specialty & Generic names. HIMS ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
120,970 | $8,692,898 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
106,646 | $3,613,163 | |
| 3 | VTRS |
Viatris Inc
|
101,570 | $1,612,928 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
85,032 | $1,363,060 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,500 | $1,354,567 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
8,222 | $912,145 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
This page
|
23,020 | $798,100 | |
| 8 | HLN |
Haleon plc
|
78,524 | $732,626 |
All Filings in HIMS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $798,100 | 23,020 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $384,515 | 18,522 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $469,935 | 14,473 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $651,482 | 11,486 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $574,119 | 11,517 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||